Welcome To Taro U.S.A.

Taro markets a broad range of prescription and over-the-counter products in the United States.  We are a leading manufacturer and supplier of topical dermatological products and also have a growing line of solid dosage form products used mainly in cardiology and neurology.

We’re proud that millions of Americans rely on our generic pharmaceuticals and over-the-counter private-label products every year.  Whether you're a physician, pharmacist or patient, please consider this website your personal resource for learning more about Taro.


Press Releases

January 12, 2012
Taro Special Committee Continues Its Evaluation of Sun Pharma's Proposal to Acquire Taro Shares
More

December 05, 2011
Taro Special Committee Appoints Citi as Financial Adviser in Connection with Sun Pharma’s Proposal to Acquire Taro Shares
More

November 15, 2011
Change to Taro's Board of Directors
More

November 10, 2011
Taro Provides 2011 Third Quarter and Year to Date Results
More

October 19,2011
Sun Pharma Proposes to Acquire Taro Shares
More

Privacy Statement   |   Terms of Use   |   Safe Harbor Statement   |   Useful Taro Links